CHEMCOM

Active

Public limited companyfounded 200025 yrs activeDrève Richelle 161 P, 1410 Waterloo, BelgiumKBO/BCE: BE 0472.909.840

Summary

CHEMCOM has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€36,451) and a net result of -€75,173. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 269 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysis Watch Report Compare

CHEMCOMActiveChecked score 42/100

Risk analysis Report Compare

Checked score

Score 2025

42 / 100

Weak

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability3▼-51

Solvency0▼-27

Growth58▲+26

Track record100

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

No credit on open account

Liquidity short (current ratio 0.79 against 2.25 in 2024; short-term debt: 126.7% and cash: 94.2% of total assets), and equity is negative.

Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 20

Relative position

BE, all sectors

reference

Manufacture of chemicals and chemical products (NACE 20)

about 43% fewer bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

-26.7%

Return on assets

-55.1%

Age of the figures

9 mo

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year -€36,451

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

24 d early

2024

333 d late

2023

47 d early

2022

26 d early

2021

58 d early

2020

87 d late

2019

58 d early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 30 days after the deadline; the sector median for financial year 2024 is 22 days before the deadline, and 27% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

27-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

History

CHEMCOM was incorporated on 29 September 2000.¹ Between 2011 and 2023 the capital was increased 7 times, most recently to EUR 3.2 million.²³⁴ The registered office was moved to Waterloo in 2025.⁵ The board currently has 8 members; Marc PARMENTIER has served longest, since 2006.⁶ Total assets fell from EUR 4.5 million in 2018 to EUR 136,368 in 2025 and headcount from 13.7 to 1 full-time equivalents.⁷

Go further with this company

How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

-€75,173▲ 59.6%

2024 · -€186,208

Working capital

-€37,040

2024 · €445,557

Trend over the years

Chart Table

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before

favourable unfavourable

Line20212022202320242025

Operating result-€1.5m▲ 16.8%-€845,026▲ 44.1%-€889,646▼ 5.3%-€168,404▲ 81.1%-€15,540▲ 90.8%

Net result-€1.4m▲ 18.9%-€739,457▲ 45.6%-€886,099▼ 19.8%-€186,208▲ 79.0%-€75,173▲ 59.6%

Equity€1.0m▼ 59.8%€664,889▼ 35.4%€241,692▼ 63.6%€38,722▼ 84.0%-€36,451

Total assets€2.1m▼ 35.8%€2.5m▲ 17.5%€2.3m▼ 9.1%€1.6m▼ 31.4%€136,368▼ 91.3%

Debt€1.1m▲ 46.3%€1.8m▲ 67.1%€2.0m▲ 10.7%€1.5m▼ 25.2%€172,819▼ 88.6%

Working capital-€481,961€694,345€840,130▲ 21.0%€445,557▼ 47.0%-€37,040

Staff (FTE)10.1▼ 19.8%8▼ 20.8%7.6▼ 5.0%6.3▼ 17.1%1▼ 84.1%

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €15,540 in 2025 against €168,404 in 2024; the loss shrinks.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €136,368

99.6%

Fixed assets €589 ▼ 99.9%

Current assets €135,779 ▼ 83.1%

Key figures and ratios

2025 value · change against 2024

EBITDA

€27,760▼

2024 · €294,968

Cash flow

-€31,873▼

2024 · €277,165

Solvency

-26.7%▼

2024 · 2.5%

Current ratio

0.79▼

2024 · 2.25

Debt to equity

-4.74▼

2024 · 39.26

ROA

-55.1%▼

2024 · -11.9%

Interest coverage

0.41▼

2024 · 8.53

Debt ≤ 1 year

€172,819▼

2024 · €357,230

Staff costs

€12,613▼

2024 · €493,341

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,640 companies that looked in July 2024 the way this one looks now, 4.1% went bankrupt within 24 months and 84% are still going.

Micro
20 years or older
negative equity
a loss of 10% of the balance sheet or more

4.1% went bankrupt

9.9% stopped otherwise

84% still going

A further 2.0% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.3% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.4%
3	0.5%	0.5%
4	0.6%	0.7%
5	0.8%	0.9%
6	1.2%	1.3%
7	1.5%	1.6%
8	1.7%	1.7%
9	2.7%	2.8%
10	5.3%	5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,640 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines

Balance sheet Code20242025

Assets

Total assets20/58€1.6m€136,368▼

Fixed assets21/28€756,246€589▼

Intangible fixed assets21€742,674-

Tangible fixed assets22/27€12,620-

Plant, machinery and equipment23€12,615-

Furniture and vehicles24€5-

Financial fixed assets28€952€589▼

Current assets29/58€802,787€135,779▼

Amounts receivable within one year40/41€671,480€7,255▼

Trade receivables40€541,795€2,625▼

Other amounts receivable41€129,685€4,630▼

Cash at bank and in hand54/58€126,409€128,524▲

Deferred charges and accrued income490/1€4,898-

Equity and liabilities

Total equity and liabilities10/49€1.6m€136,368▼

Equity10/15€38,722-€36,451▼

Contributions10/11€3.2m€3.2m=

Capital10€3.2m€3.2m=

Issued capital100€3.2m€3.2m=

Reserves13€13,901€13,901=

Non-distributable reserves130/1€13,901€13,901=

Legal reserve130€13,901€13,901=

Profit (loss) carried forward14-€3.2m-€3.2m▼

Amounts payable17/49€1.5m€172,819▼

Amounts payable after more than one year17€1.2m-

Financial debts170/4€1.2m-

Amounts payable within one year42/48€357,230€172,819▼

Trade debts44€299,699€2,180▼

Suppliers440/4€299,699€2,180▼

Taxes, remuneration and social security45€54,037-

Remuneration and social security454/9€54,037-

Other amounts payable47/48€3,494€170,640▲

Accrued charges and deferred income492/3€1,236-

Income statement Code20242025

Remuneration, social security and pensions62€493,341€12,613▼

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€463,373€43,300▼

Other operating charges640/8€16,574-

Gross operating margin9900€804,883€40,372▼

Operating profit (loss)9901-€168,404-€15,540▲

Financial income75/76B€16,764€8,101▼

Recurring financial income75€16,764€8,101▼

Financial charges65/66B€34,567€67,734▲

Recurring financial charges65€34,567€67,734▲

Profit (loss) for the period before taxes9903-€186,207-€75,173▲

Income taxes67/77€1-

Profit (loss) for the period9904-€186,208-€75,173▲

Profit (loss) for the period to be appropriated9905-€186,208-€75,173▲

Appropriation of the result

Profit (loss) to be appropriated9906-€3.2m-€3.2m▼

Profit (loss) brought forward from the previous period14P-€3.0m-€3.2m▼

Social balance

Average headcount (FTE)90876.31.0▼

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line	2021	2022	2023	2024	2025	Change
Non-recurring operating income76A	-	€547,645	-	-	-	-
Remuneration, social security and pensions62	€596,723	€574,088	€590,215	€493,341	€12,613	▼ 97.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€859,435	€464,872	€520,034	€463,373	€43,300	▼ 90.7%
Other operating charges640/8	€33,659	€34,846	€31,775	€16,574	-	-
Non-recurring operating charges66A	-	€3,204	-	-	-	-
Gross operating margin9900	-€20,977	€231,984	€252,379	€804,883	€40,372	▼ 95.0%
Operating profit (loss)9901	-€1.5m	-€845,026	-€889,646	-€168,404	-€15,540	▲ 90.8%
Financial income75/76B	€172,586	€152,040	€37,717	€16,764	€8,101	▼ 51.7%
Recurring financial income75	€172,586	€152,040	€37,717	€16,764	€8,101	▼ 51.7%
Financial charges65/66B	€21,841	€46,471	€34,170	€34,567	€67,734	▲ 95.9%
Recurring financial charges65	€21,841	€46,471	€34,170	€34,567	€67,734	▲ 95.9%
Profit (loss) for the period before taxes9903	-€1.4m	-€739,457	-€886,099	-€186,207	-€75,173	▲ 59.6%
Income taxes67/77	-	-	-	€1	-	-
Profit (loss) for the period9904	-€1.4m	-€739,457	-€886,099	-€186,208	-€75,173	▲ 59.6%
Profit (loss) for the period to be appropriated9905	-€1.4m	-€739,457	-€886,099	-€186,208	-€75,173	▲ 59.6%

Line	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€2.1m	€2.5m	€2.3m	€1.6m	€136,368	▼ 91.3%
Fixed assets21/28	€1.6m	€1.1m	€1.1m	€756,246	€589	▼ 99.9%
Intangible fixed assets21	€1.0m	€556,312	€679,526	€742,674	-	-
Tangible fixed assets22/27	€630,815	€540,761	€462,152	€12,620	-	-
Land and buildings22	€577,164	€510,295	€443,427	-	-	-
Plant, machinery and equipment23	€49,659	€29,273	€18,658	€12,615	-	-
Furniture and vehicles24	€3,993	€1,193	€67	€5	-	-
Financial fixed assets28	€952	€952	€952	€952	€589	▼ 38.1%
Current assets29/58	€482,184	€1.4m	€1.1m	€802,787	€135,779	▼ 83.1%
Amounts receivable after more than one year29	-	€600,000	-	-	-	-
Trade receivables290	-	€600,000	-	-	-	-
Amounts receivable within one year40/41	€101,496	€391,528	€773,542	€671,480	€7,255	▼ 98.9%
Trade receivables40	€32,541	€372,129	€707,577	€541,795	€2,625	▼ 99.5%
Other amounts receivable41	€68,955	€19,399	€65,966	€129,685	€4,630	▼ 96.4%
Cash at bank and in hand54/58	€380,688	€409,714	€356,691	€126,409	€128,524	▲ 1.7%
Deferred charges and accrued income490/1	-	-	-	€4,898	-	-
Equity and liabilities
Total equity and liabilities10/49	€2.1m	€2.5m	€2.3m	€1.6m	€136,368	▼ 91.3%
Equity10/15	€1.0m	€664,889	€241,692	€38,722	-€36,451	▼ 194%
Contributions10/11	€5.8m	€2.7m	€3.2m	€3.2m	€3.2m	=
Capital10	€3.8m	€2.7m	€3.2m	€3.2m	€3.2m	=
Issued capital100	€3.8m	€2.7m	€3.2m	€3.2m	€3.2m	=
Outside capital11	€2.0m	-	-	-	-	-
Share premium1100/10	€2.0m	-	-	-	-	-
Reserves13	€13,901	€13,901	€13,901	€13,901	€13,901	=
Non-distributable reserves130/1	€13,901	€13,901	€13,901	€13,901	€13,901	=
Legal reserve130	€13,901	€13,901	€13,901	€13,901	€13,901	=
Profit (loss) carried forward14	-€5.0m	-€2.1m	-€3.0m	-€3.2m	-€3.2m	▼ 2.4%
Investment grants15	€178,070	€53,834	€16,761	-	-	-
Amounts payable17/49	€1.1m	€1.8m	€2.0m	€1.5m	€172,819	▼ 88.6%
Amounts payable after more than one year17	€133,010	€1.1m	€1.7m	€1.2m	-	-
Financial debts170/4	€133,010	€1.1m	€1.7m	€1.2m	-	-
Amounts payable within one year42/48	€964,145	€706,896	€290,104	€357,230	€172,819	▼ 51.6%
Current portion of amounts payable after more than one year42	€115,268	€122,466	€10,544	-	-	-
Trade debts44	€268,931	€285,780	€209,401	€299,699	€2,180	▼ 99.3%
Suppliers440/4	€268,931	€285,780	€209,401	€299,699	€2,180	▼ 99.3%
Taxes, remuneration and social security45	€79,435	€294,046	€70,159	€54,037	-	-
Taxes450/3	€12,822	€233,147	€5,751	-	-	-
Remuneration and social security454/9	€66,613	€60,899	€64,408	€54,037	-	-
Other amounts payable47/48	€500,511	€4,605	-	€3,494	€170,640	▲ 4,784%
Accrued charges and deferred income492/3	€743	€16,937	€41,068	€1,236	-	-

Line	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	-€1.4m	-€739,457	-€886,099	-€186,208	-€75,173	▲ 59.6%
+ Depreciation and write-downs630	€859,435	€464,872	€520,034	€463,373	€43,300	▼ 90.7%
Operating cash flow (approximation)	-€500,614	-€274,585	-€366,065	€277,165	-€31,873	▼ 111%
Investment in fixed assets (approximation)	-	€81,396	-€564,638	-€76,989	€712,357	▲ 1,025%
Change in cash	-	€29,025	-€53,022	-€230,282	€2,115	▲ 101%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

All 39Financial 2Gazette 27Filings 10

Next filing, fiscal year 2026, expected by 31-07-2027

2026

09-09

State Gazette act Appointments: Joëlle DUMONT (director) and Nathalie Delwart (director)

Permanent representatives: Joëlle DUMONT, Thibaut HOFMAN and Gaëtan WAUCQUEZ7 facts ▸

General meeting, 30-06-2026
Director appointment, Joëlle DUMONT (director)
Permanent representative, Joëlle DUMONT (permanent representative)
Director appointment, Nathalie Delwart (director)
Director in office, HEXAGON ADVISORY SRL (director)
Permanent representative, Thibaut HOFMAN (permanent representative)
Permanent representative, Gaëtan WAUCQUEZ (permanent representative)

07-07

NBB filing Annual accounts filed

fiscal year 2025 · full schema

29-06

State Gazette act Appointments: Joëlle Dumont (director) and Nathalie Delwart (director)

Permanent representative: Joëlle Dumont · Resignation: Gilbert Vassart (director)5 facts ▸

General meeting, 29-05-2026
Director appointment, Joëlle Dumont (director)
Permanent representative, Joëlle Dumont
Director resignation, Gilbert Vassart (director)
Director appointment, Nathalie Delwart (director)

29-06

State Gazette act Resignations: Conthegas Consulting SRL (director) and Charles Delwart (director)

Appointments: HEXAGON ADVISORY SRL (director) and Gaëtan WAUCQUEZ (director) · Permanent representative: Thibaut Hofman6 facts ▸

Board meeting, 04-06-2026
Director resignation, Conthegas Consulting SRL (director)
Director resignation, Charles Delwart (director)
Director appointment, HEXAGON ADVISORY SRL (director)
Permanent representative, Thibaut Hofman
Director appointment, Gaëtan WAUCQUEZ (director)

29-06

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 333 days late

2025

11-12

State Gazette act Registered office · Statutes amendment

Registered-office move3 facts ▸

General meeting, 13-08-2025
Registered-office move, Drève Richelle 161, 1410 Waterloo
Statutes amendment

2024

16-09

State Gazette act Reappointments: COVORIM, CONTHEGAS CONSULTING and 5 others

Permanent representatives: Benedikt Van der Vorst, Jean-François Pollet and 3 others · Resignation: RSM Réviseurs d'Entreprises - Bedrijfsrevisoren SCRL (statutory auditor) · Appointment: EY Bedrijfsrevisoren (statutory auditor)15 facts ▸

General meeting, 31-05-2024
Director reappointment, COVORIM (director)
Permanent representative, Benedikt Van der Vorst
Director reappointment, CONTHEGAS CONSULTING (director)
Permanent representative, Jean-François Pollet
Director reappointment, HEXAGON ADVISORY SRL (director)
Permanent representative, Thibaut Hofman
Director reappointment, A.M.I.R. (director)
Permanent representative, Gilbert Vassart
Director reappointment, Gaëtan Waucquez (director)
Director reappointment, Marc Parmentier (director)
Director reappointment, Charles Delwart (director)
+3 further facts in this act

14-06

NBB filing Annual accounts filed

fiscal year 2023 · full schema

2023

18-08

State Gazette act Appointment: Gilbert Vassart (director)

Resignation: Jacques Dumont (director) · Permanent representatives: Gilbert Vassart, Thibaut Hofman and Jean-François Pollet8 facts ▸

General meeting, 28-06-2023
Director appointment, Gilbert Vassart (director)
Director resignation, Jacques Dumont
Permanent representative, Gilbert Vassart
Board composition, Hexagon Advisory SRL (director)
Permanent representative, Thibaut Hofman
Board composition, Conthegas Consulting SPRL (director)
Permanent representative, Jean-François Pollet

05-07

NBB filing Annual accounts filed

fiscal year 2022 · full schema

15-06

State Gazette act Resignation: Jean-Marie Delwart (chair of the board)

Permanent representatives: Thibaut Hofman and Jean-François Pollet6 facts ▸

Board meeting, 17-06-2022
Director resignation, Jean-Marie Delwart (chair of the board)
Board composition, Hexagon Advisory SRL (director)
Permanent representative, Thibaut Hofman
Board composition, Conthegas Consulting spri (director)
Permanent representative, Jean-François Pollet

03-04

State Gazette act Capital & shares

Capital increase · Share issue · Bank account6 facts ▸

General meeting, 22-03-2023
Capital increase, €499.974,63
Share issue, nominatives, 17975
Bank account, BNP Paribas Fortis, BE41 0019 4734 3910
Capital, €3.196.634,63
Statutes amendment

Show earlier events

2022

31-12

Financial Liquidity quadruplescurrent ratio 1.98

Current ratio from 0.50 to 1.98; short-term debt falls from €964,145 to €706,896.

03-06

NBB filing Annual accounts filed

fiscal year 2021 · full schema

20-05

State Gazette act Capital & shares

Approval · Capital increase · Capital9 facts ▸

General meeting, 29-04-2022
Approval, 29-04-2022
Capital increase, €500.002,44
Capital, €4.328.951,71
Bond issue, obligations convertibles, 39547
Capital increase, €2.012.364,64
Capital decrease, €3.644.656,35
Capital, €2.696.660
Statutes amendment

07-01

State Gazette act Resignations: Nathalie Delwart (director) and Florinvest SA (director)

Appointments: Charles Delwart, Hexagon Advisory SRL and RSM Réviseurs d'Entreprises · Permanent representatives: Thibaut Hofman and Gert Van Leemput10 facts ▸

General meeting, 11-10-2021
Director resignation, Nathalie Delwart (director)
Director resignation, Florinvest SA (director)
Director appointment, Charles Delwart (director)
Director appointment, Hexagon Advisory SRL (director)
Permanent representative, Thibaut Hofman
Auditor appointment, RSM Réviseurs d'Entreprises
Permanent representative, Gert Van Leemput
Board composition, Gaëtan Waucquez (director)
Board composition, Hexagon Advisory SRL (director)

2021

26-10

NBB filing Annual accounts filed

fiscal year 2020 · full schema · 87 days late

05-02

State Gazette act Capital & shares · Statutes amendment

Capital increase · Bank account · Capital4 facts ▸

General meeting, 22-12-2020
Capital increase, €1.159.996,76
Bank account, BNP Paribas Fortis, BE63 0018 9777 6708
Capital, €3.828.949,27

2020

31-12

Financial Weakest financial yearnet -€1.7m

Net result drops to -€1.7m, the lowest in the series; recovery starts the following year.

18-08

State Gazette act Capital & shares · Statutes amendment

Capital · Capital increase · Bank account5 facts ▸

General meeting, 29-05-2020
Statutes amendment
Capital, €2.268.972,81
Capital increase, €399.979,7
Bank account, BNP Paribas Fortis, BE11 0018 8521 9248

30-07

State Gazette act Reappointment: Mazars SC scrl (statutory auditor)

Permanent representative: Christian Van Osselaer3 facts ▸

General meeting, 29-05-2020
Auditor reappointment, Mazars SC scrl
Permanent representative, Christian Van Osselaer

03-06

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2019

06-08

State Gazette act Appointments: COVORIM sprl (director) and CONTHEGAS CONSULTING sprl (director)

Permanent representatives: Benedikt Van der Vorst and Jean-François Pollet5 facts ▸

General meeting, 03-06-2019
Director appointment, COVORIM sprl (director)
Permanent representative, Benedikt Van der Vorst
Director appointment, CONTHEGAS CONSULTING sprl (director)
Permanent representative, Jean-François Pollet

13-06

NBB filing Annual accounts filed

fiscal year 2018 · full schema

2018

17-09

State Gazette act Capital & shares

Capital increase · Bank account · Net-asset statement6 facts ▸

Capital increase, €1.600.141,32
Bank account, BNP PARIBAS FORTIS, BE27 0018 4414 2273
Capital increase, €581.110,98
Net-asset statement, 30-06-2018
Capital, €2.268.972,81
Statutes amendment

31-07

State Gazette act Reappointments: Biotec SA, Florinvest SA and 4 others

Permanent representatives: Jean-Marie Delwart and Christian Van Osselaer · Intermediary10 facts ▸

General meeting, 25-05-2018
Director reappointment, Biotec SA (director)
Director reappointment, Florinvest SA (director)
Director reappointment, Gaëtan Waucquez (director)
Director reappointment, Nathalie Delwart (director)
Director reappointment, Marc Parmentier (director)
Director reappointment, Jacques Dumont (director)
Permanent representative, Jean-Marie Delwart
Permanent representative, Christian Van Osselaer
Intermediary, Florinvest SA

31-05

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

01-08

State Gazette act Reappointment: Mazars (statutory auditor)

Permanent representative: BIOTRAC spri3 facts ▸

General meeting, 29-06-2017
Auditor reappointment, Mazars
Permanent representative, BIOTRAC spri

11-07

NBB filing Annual accounts filed

fiscal year 2016 · full schema

2016

21-01

State Gazette act Capital & shares · Statutes amendment

Capital decrease · Capital · Power of attorney5 facts ▸

General meeting, 17-12-2015
Capital decrease, €4.400.000
Capital, €87.720,51
Statutes amendment
Power of attorney, Conseil d'administration

2015

08-01

State Gazette act Capital & shares

Capital increase · Capital · Power of attorney4 facts ▸

General meeting, 03-12-2014
Capital increase, €1.000.060,51
Capital, €4.487.720,51
Power of attorney, Conseil d'administration

2014

01-07

State Gazette act Reappointment: Mazars (statutory auditor)

Permanent representative: Christian Van Osselaer3 facts ▸

General meeting, 30-05-2014
Auditor reappointment, Mazars
Permanent representative, Christian Van Osselaer

2012

06-09

State Gazette act Resignation: COMPAGNIE DU BOIS SAUVAGE SA (director)

Reappointments: Biotec SA, Florinvest SA and 4 others · Permanent representative: Christian Van Osselaer9 facts ▸

General meeting, 22-08-2012
Director resignation, COMPAGNIE DU BOIS SAUVAGE SA (director)
Director reappointment, Biotec SA (director)
Director reappointment, Florinvest SA (director)
Director reappointment, Gaëtan Waucquez (director)
Director reappointment, Nathalie Delwart (director)
Director reappointment, Marc Parmentier (director)
Director reappointment, Jacques Dumont (director)
Permanent representative, Christian Van Osselaer

2011

18-10

State Gazette act Capital & shares · Statutes amendment

Capital increase · Power of attorney6 facts ▸

General meeting, 23-09-2011
Statutes amendment
Statutes amendment
Statutes amendment
Capital increase, €179.760
Power of attorney, Conseil d'administration de CHEMCOM

03-08

State Gazette act Reappointments: Jacques Dumont (director) and Gaëtan Waucquez (director)

Appointments: Compagnie du Bois Sauvage, Nathalie Delwart and Mazars · Permanent representatives: Laurent Puissant Bayens and Philippe Gossart · Resignation: Charles Delwart (director)11 facts ▸

General meeting, 27-05-2011
Director reappointment, Jacques Dumont (director)
Director reappointment, Gaëtan Waucquez (director)
Director appointment, Compagnie du Bois Sauvage (director)
Permanent representative, Laurent Puissant Bayens
Director appointment, Nathalie Delwart (director)
Director resignation, Charles Delwart (director)
Auditor appointment, Mazars (statutory auditor)
Mandate compensation, Mazars
Permanent representative, Philippe Gossart
Board decision ratification, Conseil d'Administration du 15 octobre 2010 et du 11 mai 2011

2010

28-07

State Gazette act Resignation: Alexandre Schmitz (director)

Permanent representatives: Christian VAN OSSELAER and Gaëtan WAUCQUEZ4 facts ▸

General meeting, 28-05-2010
Director resignation, Alexandre Schmitz (director)
Permanent representative, Christian VAN OSSELAER
Permanent representative, Gaëtan WAUCQUEZ

2008

15-07

State Gazette act Appointments: SCPRL Chartes de Streel (statutory auditor) and Laurent Puissant Baeyens (représentant de metrobel s.a.)

Resignation: Guy Paquot (représentant de metrobel s.a.) · Reappointment: EUROSCREEN (director) · Permanent representatives: Jean-Marie DELWART and Christian VAN OSSELAER7 facts ▸

General meeting, 30-05-2008
Auditor appointment, SCPRL Chartes de Streel (statutory auditor)
Director appointment, Laurent Puissant Baeyens (représentant de metrobel s.a.)
Director resignation, Guy Paquot (représentant de metrobel s.a.)
Director reappointment, EUROSCREEN (director)
Permanent representative, Jean-Marie DELWART
Permanent representative, Christian VAN OSSELAER

2007

31-05

State Gazette act Capital & shares · Miscellaneous

Demerger · Power of attorney4 facts ▸

Demerger, Apport par la société Chemcom de sa branche d'activité « olfaction humaine » à la société Tecnoscent Flonnvest SA
Power of attorney, Biotrac SPRL
Power of attorney, Christian Van Osselaer
Power of attorney, Jean-Marie Delwart

2006

08-09

State Gazette act Reappointments: BIOTEC, FLORINVEST and Marc Parmentier

Permanent representatives: Jean-Marie Delwart, BIOTRAC SPRL and Christian Van Osselaer7 facts ▸

General meeting, 26-05-2006
Director reappointment, BIOTEC (director)
Permanent representative, Jean-Marie Delwart
Director reappointment, FLORINVEST (director)
Permanent representative, BIOTRAC SPRL
Permanent representative, Christian Van Osselaer
Director reappointment, Marc Parmentier (director)

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

27 of 27 acts read

Directors · office · real estate

Directors

8 directors, no change since 2026

Board 8

Marc PARMENTIER

Director · since 26-05-2006

Current

Gäetan Waucquez

Director · since 28-05-2010

Current

HEXAGON ADVISORY SRL

Director · since 11-10-2021 · Legal entity · perm. rep.: Thibaut Hofman

Current

A.M.I.R.

Director · since 31-05-2024 · Legal entity · perm. rep.: Gilbert Vassart

Current

CONTHEGAS CONSULTING

Director · since 31-05-2024 · Legal entity · perm. rep.: Jean-François Pollet

Current

COVORIM

Director · since 31-05-2024 · Legal entity · perm. rep.: Benedikt Van der Vorst

Current

Joëlle Dumont

Director · since 29-05-2026

Current

Nathalie Delwart

Director · since 29-05-2026

Current

6 not recently confirmed

Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.

Biotec

Director · since 26-05-2006 · Legal entity · perm. rep.: Jean-Marie Delwart

Not recently confirmed

FLORINVEST

Director · since 26-05-2006 · Legal entity

Not recently confirmed

EUROSCREEN

Director · since 30-05-2008 · Legal entity

Not recently confirmed

Compagnie Du Bois Sauvage

Director · since 27-05-2011 · Legal entity · perm. rep.: Laurent Puissant Bayens

Not recently confirmed

Biotec sa

Director · since 25-05-2018 · Legal entity · perm. rep.: Jean-Marie Delwart

Not recently confirmed

COVORIM

Director · since 03-06-2019 · Private limited company · perm. rep.: Benedikt Van der Vorst

Not recently confirmed

Permanent representatives 4

Thibaut Hofman

Permanent representative · since 11-10-2021 · for HEXAGON ADVISORY SRL

Current

Benedikt Van der Vorst

Permanent representative · since 31-05-2024 · for COVORIM

Current

Gilbert Vassart

Permanent representative · since 31-05-2024 · for A.M.I.R.

Current

Jean-François Pollet

Permanent representative · since 31-05-2024 · for CONTHEGAS CONSULTING

Current

3 not recently confirmed

Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.

Laurent Puissant Baeyens

Représentant de metrobel s.a. · since 30-05-2008

Not recently confirmed

Laurent Puissant Bayens

Permanent representative · since 27-05-2011 · for Compagnie Du Bois Sauvage

Not recently confirmed

Jean-Marie Delwart

Permanent representative · since 25-05-2018 · for Biotec sa

Not recently confirmed

Statutory auditor 1

Ernst et Young Reviseurs d'Entreprises

Statutory auditor · since 31-05-2024 · perm. rep.: Carlo-Sébastien D'Addario

Current

Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →

Location & real-estate footprint

Registered office, Waterloo · 1 establishment unit since 2001

seat establishment The establishment unit on the map

Ground area

1.2 ha

Building footprint

2,260 m²

Volume, LiDAR

37,294 m³

2 parcels, Brussels, Wallonia · tallest building 22.9 m, ±6 floors. Linked by address, not a title deed.

10 companies at this address See who is registered here

1 establishment unit

CHEMCOM

Lennikse Baan 802, 1070 AnderlechtScientific research and development

since 20012.098.181.165

2 parcels

Wallonia 1 (50%) Brussels 1 (50%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25763M0621/00F000indicative	Wallonia	1.0 ha	1 · 1,772 m²	22.9 m · 6 fl.
21307E0036/00B003	Brussels	1,843 m²	1 · 487 m²	20.9 m · 2 fl.

Linked by address, not proof of ownership

Good to know

1 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Mandate history

28 people since 2006, 16 in office

All 28 In office 16 Ended 12

Board
Permanent representative
Statutory auditor
not recently confirmed
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
Marc PARMENTIER	Director, already before 26-05-2006 to date
Gäetan Waucquez	Director, already before 28-05-2010 to date
Nathalie Delwart	Director, from 27-05-2011 to 11-10-2021 Director, from 29-05-2026 to date
HEXAGON ADVISORY SRL	Director, from 11-10-2021 to date
A.M.I.R.	Director, already before 31-05-2024 to date
CONTHEGAS CONSULTING	Director, already before 31-05-2024 to date
COVORIM	Director, already before 31-05-2024 to date
Joëlle Dumont	Director, from 29-05-2026 to date
Ernst et Young Reviseurs d'Entreprises	Statutory auditor, from 31-05-2024 to date
Biotec	Director, already before 26-05-2006 not ended, last confirmed 08-09-2006
FLORINVEST	Director, already before 26-05-2006 not ended, last confirmed 08-09-2006
EUROSCREEN	Director, already before 30-05-2008 not ended, last confirmed 15-07-2008
Compagnie Du Bois Sauvage	Director, from 27-05-2011 not ended, last confirmed 03-08-2011
Biotec sa	Director, already before 06-09-2012 not ended, last confirmed 31-07-2018
COVORIM	Director, from 03-06-2019 not ended, last confirmed 06-08-2019
Laurent Puissant Baeyens	Représentant de metrobel s.a., from 30-05-2008 not ended, last confirmed 15-07-2008
Charles Delwart	Director, until 27-05-2011 Director, from 11-10-2021 to 29-05-2026
Gilbert Vassart	Director, from 28-06-2023 to 29-05-2026
CONTHEGAS CONSULTING	Director, from 03-06-2019 to 28-02-2025
RSM Reviseurs d'Entreprises-Bedrijfsrevisoren	Auditor, from 11-10-2021 to 31-05-2024
Jacques Dumont	Director, already before 28-05-2010 to 28-06-2023
Jean-Marie Delwart	Chair of the board, until 07-07-2022
Florinvest SA	Director, already before 06-09-2012 to 11-10-2021
Mazars SC scrl	Auditor, from 27-05-2011 to 11-10-2021
COMPAGNIE DU BOIS SAUVAGE SA	Director, until 22-08-2012
SCPRL Chartes de Streel	Statutory auditor, from 30-05-2008 to 27-05-2011
Alexandre Schmitz	Director, until 28-05-2010
Guy Paquot	Représentant de metrobel s.a., until 30-05-2008

Show all 28 people Show the first 12See the board, name and seat on a given date →

Articles of association

Purpose

La recherche, la mise au point et le développement de produits nouveaux et de procédés novateurs issus du développement des techniques de biologie et de génétique moléculaires dans…

Full purpose

La recherche, la mise au point et le développement de produits nouveaux et de procédés novateurs issus du développement des techniques de biologie et de génétique moléculaires dans le domaine médical, pharmaceutique, biologique, chimique, agro alimentaire, et particulièrement la communication chimique et les récepteurs olfactifs; la fabrication, la transformation, l'achat, la vente, la représentation, la location, l'importation ou l'exportation de tous produits, machines, matériaux, conditionnements et matières ou la fourniture de tout service en rapport avec la recherche, l'exploitation et la commercialisation de ces produits et procédés.

according to the deed of 18-08-2020

Structure & network

Owners and holdings

4 owners · 1 holding

Owners 4

Natix

Sourceaccounts Natix 2025

41.59%
Biotec

Sourceaccounts Biotec 2024

20.31%
Belgocodex

Sourceaccounts Belgocodex 2024

3.57%
ANATEO INVEST

Sourceaccounts ANATEO INVEST 2025

1.73%

Holdings 1

TECNOSCENT

Sourceown accounts 2025
Equity -€16,212Result -€363

50%

According to the 2025 annual accounts of CHEMCOM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

12 connected companies

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Linked via shared directors

AGEMAR

via Gäetan Waucquez · Director

→

Confédération belge du Cheval

via Joëlle Dumont · Director

→

Floridienne

via Gäetan Waucquez · Managing director

→

SYNDICAT- D'INITIATIVE-BRUXELLES PROMOTION 1886 SOCIETE ROYALE S.I.B.P.

via Gäetan Waucquez · Director

→

Show 8 more companies with a shared director

TRAVIE

via Gäetan Waucquez · Director

→

W. INVEST

via Gäetan Waucquez · Director and managing director

→

BANQUE DEGROOF PETERCAM

via Gäetan Waucquez · Administrateur non exécutif

former→

Elegast

via Marc PARMENTIER · Director

former→

GROUP S - SECRETARIAT SOCIAL, SECRETARIAT SOCIAL AGREE D'EMPLOYEURS

via Marc PARMENTIER · Director

former→

Institut pour le Transport par Batellerie - Instituut voor het Transport langs de Binnenwateren

via Marc PARMENTIER · Director

former→

TIBI

via Marc PARMENTIER · Director

former→

NOVADIP BIOSCIENCES

Shared corporate director

→

Acquisitions and mergers

1 transaction

Split off to:Tecnoscent Flonnvest SA

proposal · State Gazette act of 31-05-2007

Capital and shareholders

Capital over the years

03-04-2023 Capital increase of 499,974.63 EUR · to 3,196,634.63 EUR · 17,975 new shares
20-05-2022 Capital increase of 500,002.44 EUR · to 4,328,951.71 EUR · 8,988 new shares · “apport de diverses créances – avances d'actionnaires”
20-05-2022 Capital increase of 2,012,364.64 EUR · to 6,341,316.35 EUR · no new shares · from reserves
20-05-2022 Capital reduction of 3,644,656.35 EUR · to 2,696,660 EUR · to absorb losses
05-02-2021 Capital increase of 1,159,996.76 EUR · to 3,828,949.27 EUR · 20,852 new shares
18-08-2020 Capital increase of 399,979.70 EUR · to 2,668,952.51 EUR · 7,190 new shares
17-09-2018 Capital increase of 1,600,141.32 EUR · to 1,687,861.83 EUR · 28,764 new shares · in cash
17-09-2018 Capital increase of 581,110.98 EUR · to 2,268,972.81 EUR · 10,446 new shares · in kind

Show 3 older capital entries

21-01-2016 Capital reduction of 4,400,000 EUR · to 87,720.51 EUR · to absorb losses
08-01-2015 Capital increase of 1,000,060.51 EUR · to 4,487,720.51 EUR · 17,977 new shares
18-10-2011 Capital increase of 179,760 EUR · to 3,487,660 EUR · 8,988 new shares

Similar companies · same sector, comparable size

Wetteren · Eq €36,285

Of 243 companies in sector 20420 we hold annual accounts for 94. 45 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPublic limited company

Founded29-09-2000

Fiscal year end31-12

Activities, NACEBEL 2025

20420Manufacture of chemicals and chemical products

46120Wholesale trade

E-invoicing

Reachable via Peppol

Peppol ID 0208:0472909840

Registered 22-12-2025

Scores and ratios are computed by Checked and are not a credit decision.